Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


ViroVet sets ASF product commercialization timeline, moves BVD antiviral into development

Belgian biotechnology firm ViroVet is currently working on developing antivirals and vaccines for the livestock and small ruminant sectors. Animal Pharm analyst Daniel Willis spoke to the company's chief executive and co-founder Erwin Blomsma at VetHealth Global 2019 in Charlottetown, Canada, to get an update on its plans for 2019 and beyond.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts